// App-Quantinova.ai

2614 : Phase 1 study of combination carboplatin, paclitaxel, and ridaforolimus in patients with solid, endometrial, and ovarian cancers.

Researchers

Presenter

  • Hye Sook Chon

Principal Investigators

  • Patricia Lynn Judson

  • Robert Michael Wenham

  • Sachin Apte

  • Ji-Hyun Lee

  • Irene Williams-Elson

Medical Centers

  • H. Lee Moffitt Cancer Center & Research Institute, Riverview, FL

  • Biostatistics Department, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FLH. Lee Moffitt Cancer Center & Research Institute, Tampa, FLDepartment of Gynecologic Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Thrombocytopenia

  • Ovarian cancer

  • Solid malignancies

  • Neutropenia

Biomarkers

  • N/A

Drug/Treatment

  • Ridaforolimus

  • Carboplatin

  • Paclitaxel

Outcome

  • Positive

Study Design

  • pharmacokinetics

  • pharmacodynamics

Phase

  • I

Study Id's

  • NCT01256268

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved